Found 9 matching trials
Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP
PHASE2This is a phase II randomized, open-label study comparing salvage radiother...
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer
PHASE2The primary objective of the study is to determine the therapeutic dose of ...
Status
Active Not Recruiting
Location
State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary"
To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer.
PHASE3This study will recruit 168 patients in approximately 20 study centres in C...
Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
PHASE2This Investigator-initiated, Treatment of High-Risk Prostate Cancer Guided ...
Location
ZAS Sint-Augustinus
Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC
NAThis study is a single-arm prospective cohort study designed to evaluate th...
A Degarelix Trial in Patients With Prostate Cancer
PHASE3A phase III extension trial comparing the efficacy and safety of degarelix ...
Location
University of Colorado School of Medicine
A Trial of Degarelix in Patients With Prostate Cancer
PHASE3A phase 3, open-label, parallel group, one year trial comparing the efficac...
Location
Urology Centers Of Alabama
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
PHASE1This is a randomized, open-label, Parallel, active-controlled phase I study...
Location
Sun Yat-sen Memorial Hospital of Sun Yat-sen University
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
PHASE1The primary objective of this trial is to evaluate ovarian suppression foll...
Location
Genesis Cancer and Blood Institute